Comprehensive Clinical Trials Joins CytoCore, Inc.'s e2 Collector Trial

CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced that Comprehensive Clinical Trials, LLC, of West Palm Beach, Florida has begun participation as a site in CytoCore’s current e2 Collector™ clinical trial. Dr. Ronald Ackerman is the principal investigator for the e2 Collector trial at this clinical trial site.